It is unknown whether U.S. Senior District Judge Sarah Evans Barker’s amended partial final judgement in Lilly's 340B contract pharmacy lawsuit will satisfy a higher court that kicked the case back to her.
A federal district judge in Indianapolis last week responded to a higher court’s directive and entered an amended partial final judgement in drug manufacturer Lilly’s 340B contract pharmacy lawsuit. It is not clear whether the judge did enough
Sanofi made two changes to its conditions on 340B pricing when health centers and certain hospitals use contract pharmacies.
Drug manufacturer Sanofi has made two major changes to its conditions on 340B pricing when health centers and certain hospitals and use contract pharmacies, a company spokesperson confirms. One is raising flags among 340B providers and the other
The federal government told a court this week that Methodist Le Bonheur Healthcare agreed to pay a private oncology practice "for referrals and the opportunity to recoup discounts through the 340B program." Methodist has vowed to vigorously defend itself against what it says are meritless claims.
The federal government on Monday accused a Tennessee health system of unlawfully paying a Memphis-area private oncology practice for patient referrals, letting the system “recoup a staggering discount in costs” through the 340B program. The 340B health system—Methodist
Astellas is issuing 340B covered entities refunds for overcharges on Xtandi and Myrbetriq for the period from Q3 2020 through Q2 2021.
Astellas Pharma is issuing 340B covered entities refunds for overcharges on three NDCs for its prostate cancer treatment Xtandi and on four NDCs for its overactive bladder medication Myrbetriq for the period from Q3 2020 through Q2 2021.
There has been a burst of activity in federal appeals courts in drug manufacturers' 340B contract pharmacy lawsuits.
A federal appeals court in Chicago has told a lower court in Indianapolis to issue a final judgement in drug manufacturer Lilly’s 340B contract pharmacy lawsuit to clear the way for the case’s next phase.